Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolay Sappler

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Heart Rhythm|December 27, 2021
Nocturnal heart rate variability: A population-based screening tool?Nikolay Sappler, Axel Bauer
Respirology (Carlton, Vic.)|June 7, 2022
Long-term effects of discontinuing renin-angiotensin system inhibitors in COVID-19Fabian Theurl, Nikolay Sappler, Konstantinos D Rizas, et al.
American Heart Journal|July 12, 2021
Rationale and design of a digital trial using smartphones to detect subclinical atrial fibrillation in a population at risk: The eHealth-based bavarian alternative detection of Atrial Fibrillation (eBRAVE-AF) trialLuisa Freyer, Lukas von Stülpnagel, Peter Spielbichler, et al.
European Heart Journal. Digital Health|June 2, 2023
Smartwatch-derived heart rate variability: a head-to-head comparison with the gold standard in cardiovascular diseaseFabian Theurl, Michael Schreinlechner, Nikolay Sappler, et al.
Trials|December 9, 2022
Safety and efficacy of direct cardiac shockwave therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial-an updateFelix Nägele, Leo Pölzl, Michael Graber, et al.
Nature Medicine|August 28, 2022
Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trialKonstantinos D Rizas, Luisa Freyer, Nikolay Sappler, et al.
European Heart Journal|June 20, 2024
Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trialJohannes Holfeld, Felix Nägele, Leo Pölzl, et al.
Circulation|December 10, 2021
Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH SubstudyRune Boas, Nikolay Sappler, Lukas von Stülpnagel, et al.
Journal of the American College of Cardiology|September 20, 2023
Association of High-Sensitivity Cardiac Troponin T With 30-Day and 5-Year Mortality After Cardiac SurgeryLeo Pölzl, Clemens Engler, Philipp Sterzinger, et al.
The Lancet. Digital Health|January 29, 2022
Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trialAxel Bauer, Nikolay Sappler, Lukas von Stülpnagel, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Heart Rhythm|December 27, 2021
Nocturnal heart rate variability: A population-based screening tool?Nikolay Sappler, Axel Bauer
Respirology (Carlton, Vic.)|June 7, 2022
Long-term effects of discontinuing renin-angiotensin system inhibitors in COVID-19Fabian Theurl, Nikolay Sappler, Konstantinos D Rizas, et al.
American Heart Journal|July 12, 2021
Rationale and design of a digital trial using smartphones to detect subclinical atrial fibrillation in a population at risk: The eHealth-based bavarian alternative detection of Atrial Fibrillation (eBRAVE-AF) trialLuisa Freyer, Lukas von Stülpnagel, Peter Spielbichler, et al.
European Heart Journal. Digital Health|June 2, 2023
Smartwatch-derived heart rate variability: a head-to-head comparison with the gold standard in cardiovascular diseaseFabian Theurl, Michael Schreinlechner, Nikolay Sappler, et al.
Trials|December 9, 2022
Safety and efficacy of direct cardiac shockwave therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial-an updateFelix Nägele, Leo Pölzl, Michael Graber, et al.
Nature Medicine|August 28, 2022
Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trialKonstantinos D Rizas, Luisa Freyer, Nikolay Sappler, et al.
European Heart Journal|June 20, 2024
Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trialJohannes Holfeld, Felix Nägele, Leo Pölzl, et al.
Circulation|December 10, 2021
Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH SubstudyRune Boas, Nikolay Sappler, Lukas von Stülpnagel, et al.
Journal of the American College of Cardiology|September 20, 2023
Association of High-Sensitivity Cardiac Troponin T With 30-Day and 5-Year Mortality After Cardiac SurgeryLeo Pölzl, Clemens Engler, Philipp Sterzinger, et al.
The Lancet. Digital Health|January 29, 2022
Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trialAxel Bauer, Nikolay Sappler, Lukas von Stülpnagel, et al.
Pageof 2